Tumour treating fields (TTFields) therapy increases the permeability of glioblastoma multiforme (GBM) cell membrane and thus renders the cells more permeant to chemotherapeutic agents, a study has shown.
Combination therapy with the multikinase inhibitor sorafenib and tumour treating fields (TTFields) has demonstrated potential for use in glioblastoma multiforme (GBM) treatment.
Tumour treating fields (TTFields) therapy, delivered with a wearable device launched in Hong Kong recently, offers a ray of hope for patients with glioblastoma multiforme (GBM), a disease with poor prognosis despite advances in surgical, radiation and systemic treatments.
Blood pressure lowering medications and statins do not prevent cognitive and functional decline in elderly patients, according to results of the HOPE-3 trial* presented at the Scientific Sessions of the American Heart Association (AHA 2016) held recently in New Orleans, Louisiana, US.
Roshini Claire Anthony spoke with Adjunct Associate Professor Gamaliel Tan, head and senior orthopaedic consultant at Ng Teng Fong Hospital in Singapore, on how GPs can help diagnose and treat lower back pain.
Among patients with a recent acute ischaemic stroke treated with thrombolytic therapy, intensive blood pressure (BP)-lowering conferred no additional benefit in functional recovery compared with guideline-recommended BP-lowering, despite a reduced risk of intracranial haemorrhage with intensive therapy, according to results of the ENCHANTED* trial.
Nicotine may not have a neuroprotective effect on intracerebral haemorrhage (ICH) as previously suggested in animal studies, with former or current smokers demonstrating no difference in post-ICH functional outcomes compared with non-smokers, according to findings from the US-based ERICH* study.
Andexanet alfa effectively reduced anti-factor Xa activity in patients who experienced acute bleeding while on a factor Xa inhibitor*, results from the ANNEXA-4** study showed.